{"DataElement":{"publicId":"3289563","version":"1","preferredName":"Person Clinical Trial BRCA Mutation Stratification Type","preferredDefinition":"the protocol stratification factors based  related to the process of classifying patients, by tumor suppressor genes located on human chromosome 17q12-21, who are participating in the type of research study that tests how well new medical treatments or other interventions work.","longName":"3289550v1.0:3289554v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3289550","version":"1","preferredName":"Person Clinical Trial BRCA1 Mutation BRCA2 Mutation Stratification","preferredDefinition":"information related to the process of classifying patients, with mutation that is typically a heritable, permanent change in the nucleotide sequence of the either BRCA1 or BRCA2 genes, who are participating in the type of research study that tests how well new medical treatments or other interventions work.","longName":"2236731v1.0:3289548v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3289565","version":"1","preferredName":"Clinical Trial BRCA1 Mutation BRCA2 Mutation Stratification","preferredDefinition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical study.:A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA1 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA1 gene. Approximately 75% of these alterations result in a truncated form of the breast cancer type 1 susceptibility protein. Mutations in the BRCA1 gene predispose individuals to breast and ovarian cancers.:A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA2 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA2 gene. Most of these alterations result in a truncated form of the breast cancer type 2 susceptibility protein. Mutations in the BRCA2 gene predispose males to breast cancer.:The process of classifying patients into strata as part of the randomization process or for purposes of data analysis.","longName":"C15207:C19635:C19636:C25689","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial","conceptCode":"C15207","definition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"BRCA1 Gene Mutation","conceptCode":"C19635","definition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA1 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA1 gene. Approximately 75% of these alterations result in a truncated form of the breast cancer type 1 susceptibility protein. Mutations in the BRCA1 gene predispose individuals to breast and ovarian cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"BRCA2 Gene Mutation","conceptCode":"C19636","definition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA2 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA2 gene. Most of these alterations result in a truncated form of the breast cancer type 2 susceptibility protein. Mutations in the BRCA2 gene predispose males to breast cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stratification","conceptCode":"C25689","definition":"The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE9028DE-5983-8BC2-E040-BB89AD4348AC","latestVersionIndicator":"Yes","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"ONEDATA","dateModified":"2011-10-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE9028DE-581D-8BC2-E040-BB89AD4348AC","latestVersionIndicator":"Yes","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3289554","version":"1","preferredName":"Person Clinical Trial BRCA Mutation Stratification Type","preferredDefinition":"the protocol stratification factors based on BRCA mutation status.","longName":"3289554v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"BRCA1 mutation alone","valueDescription":"BRCA1 Mutation","ValueMeaning":{"publicId":"3289556","version":"1","preferredName":"BRCA1 Mutation","longName":"3289556","preferredDefinition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA1 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA1 gene. Approximately 75% of these alterations result in a truncated form of the breast cancer type 1 susceptibility protein. Mutations in the BRCA1 gene predispose individuals to breast and ovarian cancers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRCA1 Gene Mutation","conceptCode":"C19635","definition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA1 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA1 gene. Approximately 75% of these alterations result in a truncated form of the breast cancer type 1 susceptibility protein. Mutations in the BRCA1 gene predispose individuals to breast and ovarian cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE9028DE-5870-8BC2-E040-BB89AD4348AC","latestVersionIndicator":"Yes","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE9028DE-5889-8BC2-E040-BB89AD4348AC","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"ONEDATA","dateModified":"2011-10-05","deletedIndicator":"No"},{"value":"BRCA2 mutation alone","valueDescription":"BRCA2 Mutation","ValueMeaning":{"publicId":"3289558","version":"1","preferredName":"BRCA2 Mutation","longName":"3289558","preferredDefinition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA2 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA2 gene. Most of these alterations result in a truncated form of the breast cancer type 2 susceptibility protein. Mutations in the BRCA2 gene predispose males to breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRCA2 Gene Mutation","conceptCode":"C19636","definition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA2 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA2 gene. Most of these alterations result in a truncated form of the breast cancer type 2 susceptibility protein. Mutations in the BRCA2 gene predispose males to breast cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE9028DE-5896-8BC2-E040-BB89AD4348AC","latestVersionIndicator":"Yes","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE9028DE-58AF-8BC2-E040-BB89AD4348AC","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"ONEDATA","dateModified":"2011-10-05","deletedIndicator":"No"},{"value":"No mutation","valueDescription":"No Mutation","ValueMeaning":{"publicId":"3162445","version":"1","preferredName":"No Mutation","longName":"3162445","preferredDefinition":"The non-affirmative response to a question.: Genetic alterations found in the neoplastic lesions of the animal model. These alterations are not made intentionally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation","conceptCode":"C16885","definition":"Genetic alterations found in the neoplastic lesions of the animal model. These alterations are not made intentionally.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95A93206-6912-4FB2-E040-BB89AD432824","latestVersionIndicator":"Yes","beginDate":"2010-11-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D748903C-D0D7-8322-E040-BB89AD437DD6","beginDate":"2013-03-06","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-03-06","modifiedBy":"ONEDATA","dateModified":"2013-03-06","deletedIndicator":"No"},{"value":"BRCA1 or BRCA2 mutation","valueDescription":"BRCA1 or BRCA2 mutation","ValueMeaning":{"publicId":"3693677","version":"1","preferredName":"BRCA1 or BRCA2 mutation","longName":"3693677","preferredDefinition":"BRCA1 or BRCA2 mutation present","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D748903C-D0E2-8322-E040-BB89AD437DD6","latestVersionIndicator":"Yes","beginDate":"2013-03-06","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-03-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D748903C-D0FB-8322-E040-BB89AD437DD6","beginDate":"2013-03-06","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-03-06","modifiedBy":"ONEDATA","dateModified":"2013-03-06","deletedIndicator":"No"},{"value":"Both","valueDescription":"Both","ValueMeaning":{"publicId":"2558322","version":"1","preferredName":"Both","longName":"2558322","preferredDefinition":"Two entities considered and identifed together.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Both","conceptCode":"C49636","definition":"One and the other; relating to or being two in conjunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B0DF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2009-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF8CF480-D701-8D88-E040-BB89AD4365D8","beginDate":"2014-01-09","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-09","modifiedBy":"ONEDATA","dateModified":"2014-01-09","deletedIndicator":"No"},{"value":"BRCA2","valueDescription":"BRCA2","ValueMeaning":{"publicId":"2580436","version":"1","preferredName":"BRCA2","longName":"2580436","preferredDefinition":"Breast Cancer 2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0741-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-08-04","modifiedBy":"MAESKEB","dateModified":"2007-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF8CF480-D716-8D88-E040-BB89AD4365D8","beginDate":"2014-01-09","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-09","modifiedBy":"ONEDATA","dateModified":"2014-01-09","deletedIndicator":"No"},{"value":"BRCA1","valueDescription":"BRCA1","ValueMeaning":{"publicId":"2580435","version":"1","preferredName":"BRCA1","longName":"2580435","preferredDefinition":"Breast Cancer 1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0740-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-08-04","modifiedBy":"MAESKEB","dateModified":"2007-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF8CF480-D72A-8D88-E040-BB89AD4365D8","beginDate":"2014-01-09","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-09","modifiedBy":"ONEDATA","dateModified":"2014-01-09","deletedIndicator":"No"},{"value":"No mutation or unknown","valueDescription":"No mutation or unknown","ValueMeaning":{"publicId":"4230252","version":"1","preferredName":"No mutation or unknown","longName":"4230252","preferredDefinition":"No mutation or unknown","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F4D10125-376C-A8C3-E040-BB89AD4357BD","latestVersionIndicator":"Yes","beginDate":"2014-03-17","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-03-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4D10125-3785-A8C3-E040-BB89AD4357BD","beginDate":"2014-03-17","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-03-17","modifiedBy":"ONEDATA","dateModified":"2014-03-17","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4D10125-378F-A8C3-E040-BB89AD4357BD","beginDate":"2014-03-17","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-03-17","modifiedBy":"ONEDATA","dateModified":"2014-03-17","deletedIndicator":"No"},{"value":"BRCA not tested; not appropriate for testing","valueDescription":"BRCA not tested; not appropriate for testing","ValueMeaning":{"publicId":"4232656","version":"1","preferredName":"BRCA not tested; not appropriate for testing","longName":"4232656","preferredDefinition":"BRCA not tested; not appropriate for testing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F4E8D75D-64F5-D486-E040-BB89AD435891","latestVersionIndicator":"Yes","beginDate":"2014-03-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4E8D75D-650E-D486-E040-BB89AD435891","beginDate":"2014-03-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-03-18","modifiedBy":"ONEDATA","dateModified":"2014-03-18","deletedIndicator":"No"},{"value":"BRCA not tested; appropriate for testing","valueDescription":"BRCA not tested; appropriate for testing","ValueMeaning":{"publicId":"4232657","version":"1","preferredName":"BRCA not tested; appropriate for testing","longName":"4232657","preferredDefinition":"BRCA not tested; appropriate for testing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F4E8D75D-6518-D486-E040-BB89AD435891","latestVersionIndicator":"Yes","beginDate":"2014-03-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4E8D75D-6531-D486-E040-BB89AD435891","beginDate":"2014-03-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-03-18","modifiedBy":"ONEDATA","dateModified":"2014-03-18","deletedIndicator":"No"},{"value":"BRCA tested; no mutation identified","valueDescription":"BRCA tested; no mutation identified","ValueMeaning":{"publicId":"4232658","version":"1","preferredName":"BRCA tested; no mutation identified","longName":"4232658","preferredDefinition":"BRCA tested; no mutation identified","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F4E8D75D-653B-D486-E040-BB89AD435891","latestVersionIndicator":"Yes","beginDate":"2014-03-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4E8D75D-6554-D486-E040-BB89AD435891","beginDate":"2014-03-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-03-18","modifiedBy":"ONEDATA","dateModified":"2014-03-18","deletedIndicator":"No"},{"value":"BRCA tested; mutation identified","valueDescription":"BRCA tested; mutation identified","ValueMeaning":{"publicId":"4232659","version":"1","preferredName":"BRCA tested; mutation identified","longName":"4232659","preferredDefinition":"BRCA tested; mutation identified","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F4E8D75D-655E-D486-E040-BB89AD435891","latestVersionIndicator":"Yes","beginDate":"2014-03-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4E8D75D-6577-D486-E040-BB89AD435891","beginDate":"2014-03-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-03-18","modifiedBy":"ONEDATA","dateModified":"2014-03-18","deletedIndicator":"No"},{"value":"Unknown or not collected","valueDescription":"Unknown or not collected","ValueMeaning":{"publicId":"5046835","version":"1","preferredName":"Unknown or not collected","longName":"5046835","preferredDefinition":"Unknown or not collected","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24D7A015-FB5A-B616-E050-BB89AD436CEC","latestVersionIndicator":"Yes","beginDate":"2015-11-18","endDate":null,"createdBy":"BRETTS","dateCreated":"2015-11-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24D7A015-FB73-B616-E050-BB89AD436CEC","beginDate":"2015-11-18","endDate":null,"createdBy":"BRETTS","dateCreated":"2015-11-18","modifiedBy":"ONEDATA","dateModified":"2015-11-18","deletedIndicator":"No"},{"value":"No BRCA mutation","valueDescription":"No BRCA mutation","ValueMeaning":{"publicId":"5046836","version":"1","preferredName":"No BRCA mutation","longName":"5046836","preferredDefinition":"No BRCA mutation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24D7A015-FB7D-B616-E050-BB89AD436CEC","latestVersionIndicator":"Yes","beginDate":"2015-11-18","endDate":null,"createdBy":"BRETTS","dateCreated":"2015-11-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24D7A015-FB96-B616-E050-BB89AD436CEC","beginDate":"2015-11-18","endDate":null,"createdBy":"BRETTS","dateCreated":"2015-11-18","modifiedBy":"ONEDATA","dateModified":"2015-11-18","deletedIndicator":"No"},{"value":"Known BRCA mutation, specification unknown","valueDescription":"Known BRCA mutation, specification unknown","ValueMeaning":{"publicId":"5046837","version":"1","preferredName":"Known BRCA mutation, specification unknown","longName":"5046837","preferredDefinition":"Known BRCA mutation, specification unknown","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24D7A015-FBA0-B616-E050-BB89AD436CEC","latestVersionIndicator":"Yes","beginDate":"2015-11-18","endDate":null,"createdBy":"BRETTS","dateCreated":"2015-11-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"24D7A015-FBB9-B616-E050-BB89AD436CEC","beginDate":"2015-11-18","endDate":null,"createdBy":"BRETTS","dateCreated":"2015-11-18","modifiedBy":"ONEDATA","dateModified":"2015-11-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE9028DE-5857-8BC2-E040-BB89AD4348AC","latestVersionIndicator":"Yes","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"BRETTS","dateModified":"2015-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"3289550v1.0:3289554v1.0","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"BRCA mutation","type":"Preferred Question Text","description":"BRCA mutation","url":null,"context":"CTEP"},{"name":"CRF Text 2","type":"Alternate Question Text","description":"What was the BRCA mutation type","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"BRCA status","url":null,"context":"CTEP"},{"name":"CRF_Text_3","type":"Alternate Question Text","description":"BRCA Mutation Status Known","url":null,"context":"CTEP"},{"name":"SWOG - 1","type":"Alternate Question Text","description":"Which mutation in the BRCA1/BRCA2 gene is present in the participant?","url":null,"context":"SWOG"},{"name":"BRCA Mutation Status","type":"Alternate Question Text","description":"BRCA Mutation Status","url":null,"context":"SWOG"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE9028DE-593A-8BC2-E040-BB89AD4348AC","latestVersionIndicator":"Yes","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"GDEEN","dateModified":"2023-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}